by Judy George: For More Info, Go Here…
Electrical stimulation for pediatric ADHD gets nod from FDA.
The first medical device to treat attention deficit-hyperactivity disorder (ADHD) in children won marketing approval from the FDA Friday.
The prescription-only device from NeuroSigma called the Monarch external Trigeminal Nerve Stimulation (eTNS) system, delivers low-level electrical stimulation to branches of the trigeminal nerve, sending signals to parts of the brain thought to be involved in ADHD. The pocket-sized device is designed to be used externally at night and is indicated for children aged 7-12 currently not taking prescription ADHD medication.